37 results
6-K
EX-1.1
GMDAQ
Gamida Cell Ltd
21 Dec 20
Gamida Cell Announces Pricing of $65 Million Public Offering of Ordinary Shares
4:38pm
prospectus, the Base Prospectus, General Disclosure Package (as defined below) or the Prospectus, and all other references of like import, shall … Package or the Prospectus, as the case may be. All references in this Agreement to amendments or supplements to the Registration Statement
F-1
EX-1.1
GMDAQ
Gamida Cell Ltd
24 Jun 19
Registration statement (foreign)
4:04pm
to this offering and the information included in Schedule IV hereto, all considered together (collectively, the “General Disclosure Package”), nor (ii) any … individual Issuer Limited Use Free Writing Prospectus (as defined below), when considered together with the General Disclosure Package, nor (iii) any
8-K
EX-1.1
GMDAQ
Gamida Cell Ltd
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
Prospectus, General Disclosure Package (as defined below) or the Prospectus, and all other references of like import, shall be deemed to mean and include … in the Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus, General Disclosure Package or the Prospectus
8-K
EX-1.1
GMDAQ
Gamida Cell Ltd
30 Sep 22
Gamida Cell Announces Pricing of Approximately $20 Million Public Offering of Ordinary Shares
4:02pm
preliminary prospectus, the Base Prospectus, General Disclosure Package (as defined below) or the Prospectus, and all other references of like import, shall … Disclosure Package or the Prospectus, as the case may be. All references in this Agreement to amendments or supplements to the Registration Statement
6-K
EX-1.1
GMDAQ
Gamida Cell Ltd
20 May 20
Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares
4:14pm
, General Disclosure Package (as defined below) or the Prospectus, and all other references of like import, shall be deemed to mean and include all … in the Registration Statement, the Preliminary Prospectus, any preliminary prospectus, the Base Prospectus, General Disclosure Package or the Prospectus
F-1/A
EX-1.1
qw8r1evoaoqer98drj
17 Oct 18
Registration statement (foreign) (amended)
6:06am
20-F
EX-4.13
v042ho
25 Feb 19
Annual report (foreign)
5:08pm
F-1
EX-10.13
f0pq zidx40x7ctve
24 Jun 19
Registration statement (foreign)
4:04pm
8-K
0ao7l5k rws5p92fh
20 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-99.1
bcvrwwtypi0ue ik
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
F-1
EX-10.14
4r5l tmnzme
24 Jun 19
Registration statement (foreign)
4:04pm
F-1
EX-10.8
kbba39dt81wxtflublqi
28 Sep 18
Registration statement (foreign)
4:29pm
PRE 14A
calh7ch b4j
10 Jun 22
Preliminary proxy
4:25pm
DEF 14A
k6tr5iwzbtyouf1umpf3
22 Jun 22
Definitive proxy
4:22pm